Literature DB >> 23536559

The 19th annual Prostate Cancer Foundation scientific retreat.

Guneet Walia1, Kenneth J Pienta, Jonathan W Simons, Howard R Soule.   

Abstract

Prostate Cancer Foundation (PCF) convened its 19th Annual Scientific Retreat October 25-27, 2012, in Carlsbad, CA. Each year, this event brings together diverse researchers in a collaborative forum to present and discuss new and largely unpublished findings for prostate cancer diagnosis, prognosis, and treatment and defines the challenges to ending this disease as a threat to life and well-being. Several themes resonated at the multidisciplinary meeting, notably (i) the roles of field cancerization, tumor microenvironment, epithelial plasticity, signal transduction pathways in cancer progression, and disease resistance; (ii) intratumoral heterogeneity and consequences for precision medicine; (iii) resistance mechanisms to androgen axis inhibitors; and (iv) advances in molecular imaging and therapeutics for better detection and treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23536559     DOI: 10.1158/0008-5472.CAN-12-4576

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  The changing role of imaging in clinical care.

Authors:  Rahul Aggarwal; John Kurhanewicz
Journal:  Nat Rev Urol       Date:  2014-01-14       Impact factor: 14.432

2.  Nonautophagic cytoplasmic vacuolation death induction in human PC-3M prostate cancer by curcumin through reactive oxygen species -mediated endoplasmic reticulum stress.

Authors:  Wei-Jiunn Lee; Ming-Hsien Chien; Jyh-Ming Chow; Junn-Liang Chang; Yu-Ching Wen; Yung-Wei Lin; Chao-Wen Cheng; Gi-Ming Lai; Michael Hsiao; Liang-Ming Lee
Journal:  Sci Rep       Date:  2015-05-27       Impact factor: 4.379

3.  Association and regulation of protein factors of field effect in prostate tissues.

Authors:  Kristin N Gabriel; Anna C Jones; Julie P T Nguyen; Kresta S Antillon; Sara N Janos; Heidi N Overton; Shannon M Jenkins; Emily H Frisch; Kristina A Trujillo; Marco Bisoffi
Journal:  Int J Oncol       Date:  2016-08-22       Impact factor: 5.650

Review 4.  Mast cells as a potential prognostic marker in prostate cancer.

Authors:  Gianluigi Taverna; Guido Giusti; Mauro Seveso; Rodolfo Hurle; Piergiuseppe Colombo; Sanja Stifter; Fabio Grizzi
Journal:  Dis Markers       Date:  2013-11-11       Impact factor: 3.434

5.  The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.

Authors:  Sze Ue Iris Luk; Hui Xue; Hongwei Cheng; Dong Lin; Peter W Gout; Ladan Fazli; Colin C Collins; Martin E Gleave; Yuzhuo Wang
Journal:  Oncotarget       Date:  2014-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.